The purpose of this Association is to guarantee safety, quality and stable supply of imported drugs, and to thus support the drug importation business by its member companies.
The Association operates Registered Laboratories by the Minister of Health, Labour and Welfare, which can be trustfully used by its member companies, in order to guarantee safety and quality of imported drugs. The Association also holds workshops, seminars and briefings concerning the Pharmaceutical Affairs Law. The following committees are also established.
Discusses general operations of the Association, including its administration and financial affairs, etc., and develops measures required for activities of the Association.
Discusses laboratory operation that constantly satisfies needs from member companies, toward improved testing precision, techniques and speed in order to guarantee safety and quality of imported drugs.
Holds seminars and briefings, etc. for member companies in order to enhance compliance with and understanding of the Pharmaceutical Affairs Law. The Association also promotes understanding by foreign manufacturers of Japan’s pharmaceutical laws and regulations, etc. related to the importation of drugs by translating them into English, and planning briefings in English, Chinese, etc. at international exhibitions and other events. The Association also immediately notifies information concerning regulatory problems, through consultation with the relevant authorities and other organizations.
Conducts investigations and researches in an effort to abolish or reduce tariffs on active pharmaceutical ingredients and intermediates handled by member companies, and contributes to efficient importation of drugs through consultation with the relevant authorities.
Administers and operates the Association’s website in order to publish its activities to the pharmaceutical industry and other sectors both inside and outside of Japan. At international exhibitions and other events, the Association plans seminars and other activities to introduce Japan’s pharmaceutical regulatory systems to foreign manufacturers. Such activities are also published to abroad on its English website.
Achieves a solution by discussing various issues on distribution of APIs from foreign manufacturer to MAH by the way of importers.